Celldex Therapeutics, Inc. (CLDX)
31.82
+2.35
(+7.97%)
USD |
NASDAQ |
Mar 31, 15:22
Celldex Therapeutics EPS Diluted (Quarterly) : -1.223 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.270 |
| Abeona Therapeutics, Inc. | -0.3717 |
| Cell Source, Inc. | -0.021 |
| Kiora Pharmaceuticals, Inc. | -1.732 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -81.32M |
| Revenue (Quarterly) | 0.121M |
| Total Expenses (Quarterly) | 81.44M |
| Enterprise Value | 1.450B |
| Gross Profit Margin (Quarterly) | -574.4% |
| Profit Margin (Quarterly) | -67.20K% |
| Earnings Yield | -12.24% |
| Normalized Earnings Yield | -12.24 |